4-185019078-A-C

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The ENST00000338875.5(HELT):​c.150A>C​(p.Glu50Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000060 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HELT
ENST00000338875.5 missense

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.418
Variant links:
Genes affected
HELT (HGNC:33783): (helt bHLH transcription factor) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in anterior/posterior pattern specification; regulation of neurogenesis; and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including nervous system development; regulation of transcription by RNA polymerase II; and suckling behavior. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.050658256).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HELTNM_001300781.2 linkc.27+123A>C intron_variant Intron 1 of 3 ENST00000515777.6 NP_001287710.1 A6NFD8-3
HELTXM_017008186.2 linkc.150A>C p.Glu50Asp missense_variant Exon 1 of 4 XP_016863675.2
HELTNM_001300782.2 linkc.27+123A>C intron_variant Intron 1 of 3 NP_001287711.1 A6NFD8-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HELTENST00000338875.5 linkc.150A>C p.Glu50Asp missense_variant Exon 1 of 4 1 ENSP00000343464.4 A0A087WSW0
HELTENST00000515777.6 linkc.27+123A>C intron_variant Intron 1 of 3 1 NM_001300781.2 ENSP00000426033.1 A6NFD8-3
HELTENST00000505610.5 linkc.27+123A>C intron_variant Intron 1 of 3 1 ENSP00000422140.1 A6NFD8-4
HELTENST00000513599.1 linkn.115+123A>C intron_variant Intron 1 of 2 1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
9
AN:
150616
Hom.:
0
Cov.:
33
FAILED QC
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000198
Gnomad SAS
AF:
0.000212
Gnomad FIN
AF:
0.000293
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000445
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000138
AC:
20
AN:
1449972
Hom.:
0
Cov.:
31
AF XY:
0.0000125
AC XY:
9
AN XY:
721470
show subpopulations
Gnomad4 AFR exome
AF:
0.0000302
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000256
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000127
Gnomad4 OTH exome
AF:
0.0000671
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000597
AC:
9
AN:
150740
Hom.:
0
Cov.:
33
AF XY:
0.0000814
AC XY:
6
AN XY:
73672
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000199
Gnomad4 SAS
AF:
0.000212
Gnomad4 FIN
AF:
0.000293
Gnomad4 NFE
AF:
0.0000445
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 03, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.150A>C (p.E50D) alteration is located in exon 1 (coding exon 1) of the HELT gene. This alteration results from a A to C substitution at nucleotide position 150, causing the glutamic acid (E) at amino acid position 50 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
5.6
DANN
Benign
0.74
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.35
T
M_CAP
Benign
0.0029
T
MetaRNN
Benign
0.051
T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.83
N
REVEL
Benign
0.029
Sift
Benign
0.33
T
Sift4G
Benign
0.58
T
Vest4
0.20
MutPred
0.12
Gain of MoRF binding (P = 0.122);
MVP
0.18
MPC
0.31
ClinPred
0.14
T
GERP RS
-1.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1733980117; hg19: chr4-185940232; API